You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models

Alerts

Article menu

This article has a correction. Please see:

XML
Oncolytic and local immunotherapy
Original research
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address